A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03952403 · UNKNOWN
Trial details
- NCT number
- NCT03952403
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-02
- Primary completion
- 2023-10-01
- Enrollment
- 643
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.